Published
Arzneimittel mit dem Wirkstoff Perampanel (ATC: N03AX22)
Notice number: 00626248-2026
KEY INFORMATION
- Submission deadline
- • Aug 30, 2028
- Location
- 🇩🇪 Germany
- Contracting authority
- AOK Sachsen - Anhalt
- Accepted Languages
- German
- Tender type
- Goods
- Contract Value
- Published date
- Sep 11, 2026
TENDER DESCRIPTION
Conclusion of non-exclusive rebate agreements pursuant to Section 130a(8) of SGB V for finished medicinal products containing the active substance perampanel (ATC: N03AX22), with the possibility to conclude the agreement at any time, within the framework of what is known as an “open-house model”. A contract will be concluded with each pharmaceutical company that meets the conditions for participation. Exclusivity is not granted. Accession and/or conclusion of the contract may take place at any time under the same conditions. No individual contract negotiations will be carried out. The earliest contract commencement date is 01.11.2026. Based on this, the contract term is at most 24 months. The contract ends on 31.10.2028 regardless of when the contract begins. If AOK Sachsen-Anhalt, during the term of the contract and in accordance with the applicable procurement-law provisions, issues calls for tenders for exclusive agreements for the active substances, the agreements concluded within the scope of this publication will be terminated in accordance with the contractual provisions. This publication is not the award of a public contract within the meaning of Section 103 of the Act…
TENDER BRIEF
Login to view all answers and insights
Unlock tender brief for freeTENDER DOCUMENTS
DIRECTORY • 2 FILES
- Tender detail pageLINK
- TED PortalLINK
Login to view and download all tender documents
Unlock documents for freeASK AI ABOUT THIS TENDER
Can a foreign company apply?
Yes, foreign companies can apply as long as they meet all the requirements set out in the procurement documents.
Login to ask more questions.
Unlock AI tender chat for freeUnlock your tender workflow
Run your first search, evaluate the results, save a daily monitor and start building a pipeline of tenders worth pursuing.